1. Clinical Overview
A fixed-dose combination of two methylxanthine derivatives, Etofylline and Theophylline, used primarily as a bronchodilator and respiratory stimulant. Etofylline is a theophylline derivative with improved solubility and a more favorable side effect profile. The combination provides synergistic bronchodilation, reduces bronchial hyperreactivity, and improves diaphragmatic contractility. It is a mainstay in the management of obstructive airway diseases in the Indian clinical setting.
| Onset | Duration | Bioavailability |
|---|---|---|
| Oral: 30-60 minutes | Approximately 6-8 hours | Etofylline: ~80-90%; Theophylline: ~90-100% (varies with formulation) |
2. Mechanism of Action
The exact mechanism is multifactorial. Primary actions include non-selective inhibition of phosphodiesterase (PDE) enzymes (especially PDE3 and PDE4), leading to increased intracellular cyclic AMP (cAMP) and cyclic GMP (cGMP). This causes relaxation of bronchial smooth muscle, inhibition of inflammatory cell activation, and stabilization of mast cells. Antagonism of adenosine A1 and A2B receptors contributes to bronchodilation and may reduce airway hyperresponsiveness. Additional effects include increased diaphragmatic contractility and mild central respiratory stimulation.
3. Indications & Uses
- Bronchial Asthma (for prophylaxis and chronic treatment)
- Chronic Obstructive Pulmonary Disease (COPD) including chronic bronchitis and emphysema
4. Dosage & Administration
Adult Dosage: One tablet (Etofylline 115mg + Theophylline 35mg) two to three times daily, preferably after meals. Maximum: 3 tablets per day. Dosage must be individualized based on clinical response and serum levels.
Administration: Take with a full glass of water, preferably after meals to reduce gastric irritation. Do not crush or chew unless advised. Maintain consistent timing of doses. Avoid taking with high-fat meals as it can increase absorption and peak levels.
5. Side Effects
Common side effects may include:
- Nausea
- Vomiting
- Headache
- Insomnia
- Nervousness
- Restlessness
- Gastric irritation/heartburn
- Increased diuresis
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Ciprofloxacin, Levofloxacin, Enoxacin | Markedly decreases theophylline clearance, leading to toxicity. | Major |
| Erythromycin, Clarithromycin | Decreases theophylline clearance. Monitor levels. | Major |
| Cimetidine, Fluvoxamine | Potent inhibitors of CYP1A2; significantly increase theophylline levels. | Major |
| Phenytoin, Phenobarbital, Carbamazepine | Increase theophylline metabolism, reducing efficacy. | Moderate |
| Rifampicin | Dramatically increases clearance, leading to subtherapeutic levels. | Major |
| Beta-blockers (e.g., Propranolol) | Antagonize bronchodilator effect; may cause bronchospasm. | Moderate |
| Lithium | Theophylline increases renal lithium excretion, reducing lithium levels. | Moderate |
| Warfarin | Theophylline may slightly potentiate anticoagulant effect. | Moderate |
7. Patient Counselling
- DO take the medicine at the same time(s) each day.
- DO take it after food to avoid stomach upset.
- DO inform all your doctors and dentists you are taking this medicine.
- DO report any persistent nausea, vomiting, rapid heartbeat, or seizures immediately.
- DONT crush or chew the tablet unless instructed.
- DONT start any new medicine (including OTC, herbal) without consulting your doctor.
- DONT smoke or use nicotine products, as they change the drug's effect.
- DONT consume large amounts of caffeine-containing products.
8. Toxicology & Storage
Overdose: Primarily due to theophylline. Mild: Nausea, vomiting, insomnia, tachycardia. Severe: Cardiac arrhythmias (ventricular), hypotension, intractable seizures, hyperthermia, hypokalemia, hyperglycemia, metabolic acidosis. Serum levels >20 mcg/mL correlate with toxicity; >40 mcg/mL can be fatal.
Storage: Store below 30°C, in a cool, dry place, protected from light and moisture. Keep out of reach of children.